Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase

Glycoconjugate Journal

Volumn 27, Issue 5, 2010, Pages 549-559

  Giorgi, M Eugenia ^a   Ratier, Laura ^b   Agusti, Rosalía ^a   Frasch, Alberto C C ^b   De Lederkremer, Rosa M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Inhibitors; PEGylation; Trans sialidase; Trypanosoma cruzi

Indexed keywords

BENZYL BETA DEXTRO GALACTOPYRANOSYL (1-6) 2 AMINO 2 DEOXY ALPHA DEXTRO GLUCOPYRANOSIDE; GLUCOPYRANOSIDE; LACTOBIONOLACTONE; LACTOSE; LACTOSE DERIVATIVE; MACROGOL; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG STABILITY; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 77955563577     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-010-9300-7     Document Type: Article

References (39)

1. C Mongardini FM Veronese 1998 Stabilization of substances in circulation Bioconjugate Chem. 9 418 450 10.1021/bc970184f (Pubitemid 28338758)
2. FM Veronese A Mero 2008 The impact of PEGylation on biological therapies BioDrugs. 22 315 329 10.2165/00063030-200822050-00004 1:CAS:528: DC%2BD1cXht1ejurjK 18778113
3. RB Greenwald 2001 PEG drugs: an overview J. Control. Release. 74 159 171 10.1016/S0168-3659(01)00331-5 1:CAS:528:DC%2BD3MXlslans7w%3D 11489492 (Pubitemid 32727618)
4. AP Chapman 2002 PEGylated antibodies and antibody fragments for improved therapy: a review Adv. Drug. Deliv. Res. 54 531 545 10.1016/S0169-409X(02)00026- 1 1:CAS:528:DC%2BD38XktFKhsr4%3D (Pubitemid 34615547)
5. M Morpurgo C Monfardini LJ Hofland M Sergi P Orsolini JM Dumont FM Veronese 2002 Selective alkylation and acylation of α and amino group with PEG in a somatostatin analogue: tailored chemistry for optimized bioconjugates Bioconjugate Chem. 13 1238 1243 10.1021/bc0100511 1:CAS:528:DC%2BD38XotF2lu74%3D (Pubitemid 35420015)
6. Y Marcus K Sasson M Fridkin Y Shechter 2008 Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin J. Med. Chem. 51 4300 4305 10.1021/jm8002558 1:CAS:528: DC%2BD1cXnsl2ku70%3D 18578475 (Pubitemid 352032454)
7. V Dixit J Van den Bossche DM Sherman DH Thompson RP Andres 2006 Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells Bioconjugate Chem. 117 603 609 10.1021/bc050335b (Pubitemid 43794369)
8. C Prego D Torres E Fernandez-Megia R Novoa-Carballal E Quiñoá MJ Alonso 2006 Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree J. Controlled Release. 111 299 308 10.1016/j.jconrel.2005.12.015 1:CAS:528: DC%2BD28Xisl2lurc%3D
9. E Fernandez-Megia R Novoa-Carballal E Quiñoá R Riguera 2007 Conjugation of bioactive ligands to PEG-grafted chitosan at the distal end of PEG Biomacromolecules 8 833 842 10.1021/bm060889x 1:CAS:528:DC%2BD2sXhslaitrs%3D 17302454 (Pubitemid 46488462)
10. IL Park TH Kim YH Park BA Shin ES Choi EH Chowdhury T Akaike CS Cho 2001 Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier J. Controlled Release 76 349 362 10.1016/S0168-3659(01)00448-5 1:CAS:528:DC%2BD3MXntVWktr8%3D (Pubitemid 32913442)
11. YS Youn DH Na SD Yoo SC Song KC Lee 2005 Carbohydrate-specifically polyethylene glycol-modified ricin A-chain with improved therapeutic potential Int. J. Biochem. Cell. Biol. 37 1525 1533 10.1016/j.biocel.2005.01.014 1:CAS:528:DC%2BD2MXjt1WjsLs%3D 15833282
12. S Salmaso A Semenzato S Bersani F Mastrotto A Scomparin P Caliceti 2008 Site-selective protein glycation and PEGylation Euro. Polym. J. 44 1378 1389 10.1016/j.eurpolymj.2008.02.021 1:CAS:528:DC%2BD1cXlslGmtbk%3D
13. S DeFrees ZG Wang R Xing AE Scott J Wang D Zopf DL Gouty ER Sjoberg K Panneerselvam EC Brinkman-Van del Linden RJ Bayer MA Tarp H Clausen 2006 GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli Glycobiology 16 833 843 10.1093/glycob/cwl004 1:CAS:528:DC%2BD28XptlSms78%3D 16717104 (Pubitemid 44390927)
14. BT Houseman M Mrksich 2002 Carbohydrate arrays for the evaluation of protein binding and enzymatic modification Chem Biol 9 443 454 10.1016/S1074-5521(02)00124-2 1:CAS:528:DC%2BD38Xjt1Cqtbs%3D 11983333 (Pubitemid 34439763)
15. R Kikkeri B Lepenies A Adibekian P Laurino PH Seeberger 2009 In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots J. Am. Chem. Soc. 131 2110 2112 10.1021/ja807711w 1:CAS:528:DC%2BD1MXht1Ohu7c%3D 19199612
16. N Kawasaki S Itoh N Hashii D Takakura Y Qin X Huang T Yamaguchi 2009 The significance of glycosylation analysis in development of biopharmaceuticals Biol. Pharm. Bull. 32 796 800 10.1248/bpb.32.796 1:CAS:528:DC%2BD1MXmsVGls7s%3D 19420744
17. A Moncayo 2003 Chagas disease: current epidemiological trends alter the interruption of vectorial and transfusional transmission in the Southern Cone countries Mem. Inst. Oswaldo. Cruz. 98 577 591 10.1590/S0074-02762003000500001 12973523
18. S Schenkman MS Jiang GW Hart V Nussenzweig 1991 A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells Cell 65 1117 1125 10.1016/0092-8674(91)90008-M 1:CAS:528:DyaK3MXmt1Oru7k%3D 1712251
19. ACC Frasch 2000 Functional diversity in the tans-sialidase and mucin families in Trypanosoma cruzi Parasitol. Today 16 282 286 10.1016/S0169-4758(00) 01698-7 1:CAS:528:DC%2BD3cXltlOhurY%3D 10858646 (Pubitemid 30447392)
20. R Agustí ME Giorgi VM Mendoza C Gallo-Rodriguez RM Lederkremer 2007 Comparative rate of sialylation by recombinant trans-sialidase and inhibitor properties of synthetic oligosaccharides from Trypanosoma cruzi mucins-containing galactofuranose and galactopyranose Bioorg. Med. Chem. 15 2611 2616 10.1016/j.bmc.2007.01.045 17292612 (Pubitemid 46367710)
21. RM Lederkremer R Agustí 2009 Glycobiology of Trypanosoma cruzi Adv. Carbohydr. Chem. Biochem. 62 311 366 10.1016/S0065-2318(09)00007-9 19501708
22. L Kröger A Scudlo J Thiem 2006 Subsequent enzymatic galactosylation and sialylation towards sialylated Thomsen-Friedenreich antigen components Adv. Synth. Catal. 348 1217 1227 10.1002/adsc.200606063 (Pubitemid 44166106)
23. S Tomlinson Pontes de Carvalho LC F Vandekerckhove V Nussenzweig 1994 Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement J. Immunol. 153 3141 3147 1:CAS:528:DyaK2cXmtVaqsbs%3D 8089492
24. VL Pereira-Chioccola A Acosta-Serrano I Correia de Almeida MA Ferguson T Souto-Padron MM Rodrigues LR Travassos S Schenkman 2000 Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies J Cell Sci 113 1299 1307 1:CAS:528:DC%2BD3cXjtFyls7k%3D 10704380
25. K Nagamune A Acosta-Serrano H Uemura R Brun C Kunz-Renggli Y Maeda MA Ferguson T Kinoshita 2004 Surface sialic acids taken from the host allow trypanosome survival in tsetse fly vectors J Exp Med. 199 1445 1450 10.1084/jem.20030635 1:CAS:528:DC%2BD2cXkt1Chu7s%3D 15136592 (Pubitemid 38685735)
26. FM Amaya A Buschiazzo T Nguyen PM Alzari 2003 The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its camparison with T. cruzi trans-sialidase J. Mol. Biol. 325 773 784 10.1016/S0022-2836(02)01306-2 1:CAS:528:DC%2BD38XpvVWltrc%3D 12507479 (Pubitemid 36268697)
27. A Buschiazzo MF Amaya ML Cremona ACC Frasch PM Alzari 2002 The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis Mol. Cell. 10 757 768 10.1016/S1097-2765(02)00680-9 1:CAS:528:DC%2BD38XosF2rtLk%3D 12419220 (Pubitemid 35339437)
28. J Neres RJ Bryce KT Douglas 2008 Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease Drug Discov. Today 13 110 117 10.1016/j.drudis.2007.12.004 1:CAS:528:DC%2BD1cXitVemsro%3D 18275908
29. S Buchini A Buschiazzo SG Withers 2008 A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors Angew. Chem. Int. Ed. Engl. 47 2700 2703 10.1002/anie.200705435 1:CAS:528:DC%2BD1cXkvFejtLg%3D 18300214
30. JH Kim HW Ryu JH Shim KH Park SG Withers 2009 Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives Chembiochem 10 2475 2479 10.1002/cbic.200900108 1:CAS:528:DC%2BD1MXht1Kis7rP 19780074
31. S Arioka M Sakagami R Uematsu H Yamaguchi H Togame H Takemoto H Hinou S Nishimura 2010 Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase Bioorg. Med. Chem. 18 1633 1640 10.1016/j.bmc.2009.12.062 1:CAS:528:DC%2BC3cXitVOns78%3D 20097567
32. R Agustí G Páris L Ratier ACC Frasch RM Lederkremer 2004 Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo Glycobiology 14 659 670 10.1093/glycob/cwh079 15070857 (Pubitemid 38923647)
33. J Mucci MG Risso MS Leguizamón ACC Frasch O Campetella 2006 The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation Cell. Microbiol. 8 1086 1095 10.1111/j.1462-5822.2006.00689.x 1:CAS:528:DC%2BD28XntFWntrg%3D 16819962 (Pubitemid 43871644)
34. R Kuhn HH Baer A Seelinger 1958 Zur Methylierung Von N-Acetylglucosamin- Derivaten Liebigs Ann. Chem. 611 236 241 10.1002/jlac.19586110121 1:CAS:528:DyaG1cXmsFKmtA%3D%3D
35. C Gallo-Rodriguez O Varela RM Lederkremer 1998 One-pot synthesis of α-D-Galf(1→4)[β-D-Galp(1→6)]-D-GlcNAc, a 'core' trisaccharide linked O-glycosidically in glycoproteins of Trypanosoma cruzi Carbohydr. Res. 305 163 170 10.1016/S0008-6215(97)00256-5
36. HS Isbell HL Frush 1963 Lactonization of aldonic acids Meth. Carbohydr. Chem. 2 16 18 1:CAS:528:DyaF3sXotFOqsA%3D%3D
37. A Nag G Mitra PC Ghosh 1996 A colorimetric assay for estimation of polyethylene glycol and polyethylene glycolated protein using ammonium ferrothiocyanate Anal. Biochem. 237 224 231 10.1006/abio.1996.0233 1:CAS:528:DyaK28XjtlOkt7s%3D 8660570 (Pubitemid 26177084)
38. RS Navath B Wang S Kannan R Romero RM Kannan 2010 Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation J. Control. Release. 142 447 456 10.1016/j.jconrel.2009.10.035 1:CAS:528:DC%2BC3cXisV2rt7w%3D 19896998
39. GA Rabinovich A Cumashi GA Bianco D Ciavardelli I Iurisci M D'Egidio E Piccolo N Tinari N Nifantiev S Iacobelli 2006 Synthetic lactulose amines: Novel class of anticancer agents that induce tumor cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis Glycobiology 16 210 220 10.1093/glycob/cwj056 1:CAS:528:DC%2BD28Xhs1SksLs%3D 16282605 (Pubitemid 43264687)